Evidence map›Paper›PMID 36630083›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2023

New isoxazolidinyl-based

Doretta Cuffaro, Riccardo Di Leo, Lidia Ciccone, Alessio Nocentini, Claudiu T Supuran, Elisa Nuti, Armando Rossello

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Oxazole-Based Molecules: Recent Advances on Biological Activities.Current topics in medicinal chemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Doretta CuffaroDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0002-8842-542X
Riccardo Di LeoDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0002-5051-1584
Lidia CicconeDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0002-2762-1929
Alessio NocentiniDepartment of Neurofarba, University of Florence, Sesto Fiorentino, Italy.ORCID 0000-0003-3342-702X
Claudiu T SupuranDepartment of Neurofarba, University of Florence, Sesto Fiorentino, Italy.ORCID 0000-0003-4262-0323
Elisa NutiDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0003-2669-5376
Armando RosselloDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0002-6795-8091
University of Pisa · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbonic anhydrases (CAs) are widespread metalloenzymes which catalyse the reversible hydration of carbon dioxide (CO

Indexed as

Carbonic AnhydrasesAminesAmino AlcoholsBrainCarbonic Anhydrase InhibitorsHumansMolecular StructureStructure-Activity RelationshipAminesAmino AlcoholsCarbonic Anhydrase InhibitorsCarbonic Anhydrasesamino alcoholsCarbonic anhydrase activatorsisoxazolinesmetalloenzymesneurodegenerative diseases

Identifiers

PMID36630083
PMCPMC9848372
OpenAlexW4315619601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.